Letter to the editors in response to: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic (Cure et al.)

Publication date: Available online 5 May 2020Source: Diabetes & Metabolic Syndrome: Clinical Research & ReviewsAuthor(s): Timur Ekiz, Murat Kara, Levent Özçakar
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research